AI augments scientific judgment — it doesn't replace it.
AlphaMeld is built on a simple bet: the biggest leverage in drug discovery isn't more data — it's better reasoning over the data we already have. We augment your scientists; we don't replace them.
Modality-agnostic.
Whether the right asset is a small molecule, antibody, peptide, ADC, or gene therapy, AlphaMeld reasons over the same biological substrate. The right therapeutic format for each program emerges from the data — not the toolkit a partner walked in with.
Small molecules
Hit-ID, lead optimization, IP runway
Biologics
Antibody design and ADC payload selection
Peptides
Targeted formats and stability engineering
Gene & cell
Disease-mechanism-aligned target nomination
Eight curated agents. One orchestration layer. Each runs as a FastAPI workflow with a deterministic interface.
Knowledge graph reasoning
Multi-hop traversal across targets, diseases, drugs, endpoints, and pathways.
Target identification
Genetic, druggability, IP, and safety priors triangulated into ranked candidate lists.
Indication discovery
From a single target, surface and prioritize additional indications.
Hypothesis validation
Stress-test hypotheses against KG and literature; produce a diligence dossier.
Trial design
Endpoint selection, phase-transition prediction, and competitor-aware positioning.
TPP audit
Compare defined Target Product Profiles against actual readouts; surface drift.
Safety assessment
On- and off-target liabilities, population signals, and competitor safety benchmarks.
Reports synthesis
Templated, diligence-grade reports with full provenance and source linking.
Who We Are
We are a global leader in leveraging AI, machine learning, and generative AI to revolutionize drug discovery and development. Guided by our mission to identify and accelerate transformative therapies for diseases with unmet medical needs, we harness the power of our cutting-edge AlphaMeld® platform to extract insights from vast and diverse data sets. This innovative approach drives the creation of groundbreaking drug programs and fosters successful collaborations with industry leaders. As trailblazers in AI-driven drug discovery, we continue to catalyze innovation and redefine possibilities in healthcare.
Culture and Commitment
At AlphaMeld® Corporation, we embrace diversity and combine technology with human expertise to drive healthcare innovation. Our mission is to improve patients' lives by addressing enduring healthcare challenges. We foster a collaborative, team-oriented environment built on trust, motivation, and shared goals, nurturing future leaders who understand their impact on others. Together, we create a vibrant workplace centered on diversity, learning, and innovation.